Home » Stocks » Agilent Technologies

Agilent Technologies, Inc. (A)

Stock Price: $98.41 USD 2.08 (2.16%)
Updated Aug 3, 2020 1:19 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 30.39B
Revenue (ttm) 5.24B
Net Income (ttm) 683.00M
Shares Out 308.78M
EPS (ttm) 2.18
PE Ratio 45.14
Forward PE 27.03
Dividend $0.72
Dividend Yield 0.73%

Stock Quote

Trading Day Aug 3, 2020
Last Price $98.41
Previous Close $96.33
Change ($) 2.08
Change (%) 2.16%
Day's Open 96.94
Day's Range 96.94 - 98.72
Day's Volume 784,277
52-Week Range 61.13 - 98.72

More Stats

Market Cap 30.39B
Enterprise Value 31.55B
Earnings Date (est) Aug 18, 2020
Ex-Dividend Date Jun 29, 2020
Shares Outstanding 308.78M
Float 307.63M
EPS (basic) 2.21
EPS (diluted) 2.18
FCF / Share 2.16
Dividend $0.72
Dividend Yield 0.73%
Earnings Yield 2.22%
FCF Yield 2.19%
Payout Ratio 31.10%
Shares Short 4.12M
Short Ratio 2.90
Short % of Float 1.34%
Beta 1.12
PE Ratio 45.14
Forward PE 27.03
P/FCF Ratio 45.63
PS Ratio 5.80
PB Ratio 6.24
Revenue 5.24B
Operating Income 792.00M
Net Income 683.00M
Free Cash Flow 666.00M
Net Cash -1.16B
Net Cash / Share -3.77
Gross Margin 53.57%
Operating Margin 15.13%
Profit Margin 13.00%
FCF Margin 12.72%
ROA 6.82%
ROE 13.81%
ROIC 22.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (15)

Buy 6
Overweight 1
Hold 6
Underweight 0
Sell 2

Analyst Consensus: Overweight

Price Target

(-8.55% downside)
Current: $98.41
Target: 90.00
*Average 12-month price target from 13 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth5.07%9.88%6.43%4.06%-0.25%3.95%-43.22%3.67%21.51%-
Gross Profit2,8052,6802,3992,1972,0411,9761,9073,6043,5292,930
Operating Income9419048076155224193861,1191,071566
Net Income1,0713166844624015497341,1531,012684
Shares Outstanding314321322326333333341348347347
Earnings Per Share3.370.972.101.401.201.622.133.272.851.94
EPS Growth247.42%-53.81%50%16.67%-25.93%-23.94%-34.86%14.74%46.91%-
Dividend Per Share0.660.600.530.4616.070.530.460.30--
Dividend Growth10.07%12.88%14.78%-97.14%2942.8%14.78%53.33%---
Operating Cash Flow1,0211,0878897935127311,1521,2281,260718
Capital Expenditures-155-176-176-139-86.00-191-193-194-170-114
Free Cash Flow8669117136544265409591,0341,090604
Cash & Equivalents1,3822,2472,6782,2892,2452,2182,6752,3513,5274,199
Total Debt2,4071,7992,0111,9041,6551,6632,6992,3622,1853,691
Net Cash / Debt-1,025448667385590555-24.00-11.001,342508
Book Value4,7484,5674,8314,2434,1675,3015,2865,1824,3083,228
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Agilent Technologies, Inc.
Country United States
Employees 16,370
CEO Michael R. McMullen

Stock Information

Ticker Symbol A
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NYSE: A
IPO Date November 18, 1999


Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.